Ann: Investor Presentation and Investor Meetings, page-61

Share price stuck in the mud for the last six years?

The company did a reverse takeover of Bone Medical at 2 cents a share.

The price is currently 13.5 cents.

Not a bad return in anyone's books.

The share price is not where it should be, no doubt.

The acne debacle was a punish.

Once FDA approves next year, this stock should be well north of 25 cents.

It also has come off a 5-6 cent base prior to the recent run.

Not sure how many other stocks are doing these sorts of returns out there given global economic conditions.

Look at companies like IHL which are now floundering, along with many other bio stocks.

Management struck gold finding an asset in a depressed market like Sofpironium Bromide. The antibiotic arm also has huge potential, along with acne once it kicks along into phase 3.

BOT still remains one of the best growth stories from the current price on the ASX. You are here because deep down you know this. Your constant down ramping is to suit your own agenda, so you can enter and make life/wife changing money like the rest of us.

Enjoy your Sunday.